As an ACPE-accredited provider, it is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all educational activities. A potential for bias may exist if a continuing education faculty member is affiliated with or has a financial interest in any organization(s) that may have a direct interest in the subject matter of the presentation. Situations involving potential bias are not inherently problematic or unethical, but the prospective audience must be made aware of the affiliation or financial interest. It is intended that any potential bias be identified openly so that the audience is provided full disclosure of the facts and may form their own judgments about the continuing education activity content.
The following speakers have no relevant financial and/or commercial relationships:
Jennifer Ach, Akintunde Akinseye, Carrie Blanchard, Ted Borgstadt, Vidya Chakravarthy, Jenny Cheung, Cameron Deml, Donna Dugan, Jamie Jenkins, Dorothy Loy, Jessica Merrey, Klodiana Myftari, Binal Patel, Dan Rehrauer, Todd Sorensen, Samuel Stolpe, Mike Umbleby.
The following speakers have a relevant financial and/or commercial relationship:
Monali Bhosle is an employee of AstraZeneca and CPESN USA.
Sarah Dean is an employee of Humana, Inc.
Joel Farley has received grant/research funding from AstraZeneca and Health Partners; has received financial support from Takeda for providing expert witness testimony.
Dani Markus is an employee of OutcomesMTM/Cardinal Health.
Sujith Ramachandran has received research funding from Radius, Inc. as a principal investigator.
Ben Urick is a consultant for Pharmacy Quality Solutions; is a CE developer for PowerPak CE; has received grant funding from Cardinal Health as a principal investigator.
Yiqiao Zhang has received research funding from Radius, Inc. as a graduate research assistant.
The Continuing Pharmacy Education (CPE) activities have been developed through a joint providership of ProCE, Inc. and the Pharmacy Quality Alliance (PQA). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of Continuing Pharmacy Education. The release date for these activities is May 13-15, May 28, and June 4, 2020. The conference registration fee covers the cost of CPE credit. Participants must complete an online post-test and evaluation for each session they attend to receive pharmacy CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. All post-tests and evaluations must be completed no later than July 10, 2020. No partial credit will be given for any individual session. The Target Audience for these CPE activities is pharmacists.
